News and Announcements
YPB Builds Strong Foundation for Accelerating Revenue Growth
- Published March 01, 2016 12:01PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
29th February 2016, ASX Announcement
Highlights:
- Development of the world’s first end to end anti-counterfeit and brand protection solution through YPB’s Protect, Detect and Connect model
- Revenue up to $1.7 million (FY 2014: $0.085 million), with strong Q4
- EBITDA loss to $5.6 million (FY 2014: $4.2 million) as YPB invests in significant R&D and marketing to exploit its outstanding platform
Global anti-counterfeit and brand protection solution company YPB Group Limited (ASX: YPB) is pleased to announce its unaudited financial results for the 12 months ended 31 December 2015 in the attached Appendix 4E.
YPB has built an outstanding end-to-end solution which is now generating global revenue. Key achievements in 2015 include:
- Accelerating global sales
- Three acquistions
- Government
- R&D
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
